“…[20] Noteworthy, pyrazolo [3,4-d]pyrimidines emerged as vital pharmaceutically relevant molecules in view of their presence as part of several approved marketed drugs such as parsaclisib, ibrutinib (Imbruvica), allopurinol (Zyloric), umbralisib (Ukoniq). [21] 2 | RESULTS AND DISCUSSION Encouraged by the above-mentioned facts and as a part of our ongoing endeavors to develop valuable heterocyclic building blocks, [22,23] feasible and straightforward synthetic routes were utilized to assemble novel fused and attached pyrazolo [3,4-d]pyrimidine derivatives, aiming to promote their synthetic potential and investigate the associated biological activities.…”